FENOFIBRATE (MICRONIZED) (fenofibrate) by Molecular Devices is acid. Approved for severe hypertriglyceridemia (tg greater than, equal to 500 mg/dl) (), type 2 diabetes mellitus and 5 more indications. First approved in 2019.
Drug data last refreshed 20h ago
acid. The pharmacological effects of fenofibric acid in both animals and humans have been extensively studied through oral administration of fenofibrate. The lipid-modifying effects of fenofibric acid seen in clinical practice have been explained in vivo in transgenic mice and in vitro in human…
Worked on FENOFIBRATE (MICRONIZED) at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Fenofibrate for Prevention of DR Worsening
Fenofibrate for Patients With COVID-19 Requiring Hospitalization
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function